Textile cos higher, as India-US trade talks boost, #GokaldasExp extends gains, up over 9% in opening hour of trade
❤1
  #StockInNews | Glenmark Pharmaceuticals’ US Arm to Launch Ropivacaine Hydrochloride Injection in Single-Dose Vials in November 2025
  #JustIn | Vikram Solar bags 148.9 MW order from Sunsure Energy
  #JustIn | Kalpataru Proj bags order worth ₹2,332 cr
  #StockInNews | Aurobindo Pharma’s arm Helix Healthcare BV incorporates Aurobindo Pharma Chile SpA in Chile
  #JustIn | #StoveKraft plans to expand retail footprint to 500 exclusive stores by April 2027
  Garuda Engg bags construction order worth ₹231 cr
  #StockInNews | Kirloskar Industries bags ₹358 crore order from ONGC for EUE tubing, pup joints, and crossovers
  
  Market News ( RBI Policy ) ( Market Quarterly Results )
HUL reports Q2; checkout the numbers
#HindustanUnilever board approved an interim dividend of Rs 19 per share.
  Vardhman Textile report its #Q2Results ;
▶️Net Profit Down 5% At ₹187 Cr Vs ₹197 Cr (YoY)
▶️Revenue Down 1% At ₹2,480 Cr Vs ₹2,505.5 Cr (YoY)
▶️EBITDA Up 6% At ₹334.3 Cr Vs ₹315.2 Cr (YoY)
▶️Margin At 13.5% Vs 12.6% (YoY)
  ▶️Net Profit Down 5% At ₹187 Cr Vs ₹197 Cr (YoY)
▶️Revenue Down 1% At ₹2,480 Cr Vs ₹2,505.5 Cr (YoY)
▶️EBITDA Up 6% At ₹334.3 Cr Vs ₹315.2 Cr (YoY)
▶️Margin At 13.5% Vs 12.6% (YoY)
#NewsAlert | Pace Digitek bags order worth ₹1,159.31 Cr from Solar Energy Corporation of India for BESS supply
  #Hindalco's plan to acquire US-based AluChem Companies for $125 million has stalled due to the federal government shutdown that has impaired a regulatory body.
  #JustIn | #CaplinPoint US Arm gets US FDA nod for Nicardipine Hydrochloride Injection
🚩Alert: #Nicardipine Injection is used for the treatment of hypertension
  🚩Alert: #Nicardipine Injection is used for the treatment of hypertension
#LaurusLabs reports #Q2Results:
👉Net profit at ₹194.5 Cr Vs ₹19.8 Cr (YoY)
👉Revenue up 35% at ₹1,653.5 Cr Vs ₹1,223.7 Cr (YoY)
👉EBITDA at ₹403.3 Cr Vs ₹178.3 Cr (YoY)
👉Margin at 24.4% Vs 14.6% (YoY)
  👉Net profit at ₹194.5 Cr Vs ₹19.8 Cr (YoY)
👉Revenue up 35% at ₹1,653.5 Cr Vs ₹1,223.7 Cr (YoY)
👉EBITDA at ₹403.3 Cr Vs ₹178.3 Cr (YoY)
👉Margin at 24.4% Vs 14.6% (YoY)
